# BD invests $10M+ to expand U.S. manufacturing of syringes and needles

BD (Becton, Dickinson and Company) announced additional investments in its U.S. manufacturing network, including over $10 million in 2024 to install new needle and syringe production lines at plants in Connecticut and Nebraska, adding hundreds of millions of units annually and hiring more than 215 employees. The company also plans over $30 million in 2025 investments to expand IV line capacity at its Utah plant.

- Type: Expansion
- Announced: 2025-01-15
- Where: Connecticut, Nebraska, Utah, United States
- Value: $10.0M
- Jobs: 215
- Status: under construction
- Capacity: hundreds of millions of units annually
- Products: syringes, needles, IV catheters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BD (Becton, Dickinson and Company)](https://endata.com/companies/23751.md)

## Sources

- [news.bd.com](https://news.bd.com/2025-01-15-BD-Boosts-U-S-Manufacturing-of-Critical-Medical-Devices), 2025-01-15: "As part of the company's 2024 investment of more than $10 million to expand manufacturing capacity, new needle and syringe production lines have been installed at the BD plants in Connecticut and Nebraska."
- [respiratory-therapy.com](https://respiratory-therapy.com/products-treatment/industry-regulatory-news/business-news/bd-boosts-us-manufacturing-of-critical-medical-devices/), 2025-02-12: "Domestic manufacturing is crucial for ensuring a resilient supply of essential health care devices."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.